| SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling C Fedele, S Li, KW Teng, CJR Foster, D Peng, H Ran, P Mita, MJ Geer, ... Journal of Experimental Medicine 218 (1), e20201414, 2020 | 173 | 2020 |
| Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian cancer S Zhang, S Iyer, H Ran, I Dolgalev, S Gu, W Wei, CJR Foster, CA Loomis, ... Cancer discovery 11 (2), 362-383, 2021 | 63 | 2021 |
| Risk-associated alterations in marrow T cells in pediatric leukemia JK Bailur, SS McCachren, K Pendleton, JC Vasquez, HS Lim, A Duffy, ... JCI insight 5 (16), 2020 | 27 | 2020 |
| Quantitative phosphoproteomic analysis reveals involvement of PD-1 in multiple T cell functions AS Tocheva, M Peled, M Strazza, KR Adam, S Lerrer, S Nayak, ... Journal of Biological Chemistry 295 (52), 18036-18050, 2020 | 23 | 2020 |
| Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian cancer. Cancer Discov. 11, 362–383. doi: 10.1158/2159-8290 S Zhang, S Iyer, H Ran, I Dolgalev, S Gu, W Wei, CJR Foster, CA Loomis, ... CD-20-0455, 2021 | 4 | 2021 |
| SHP2 Inhibition Abrogates Adaptive Resistance to KRASG12C-Inhibition and Remodels the Tumor Microenvironment of KRAS-Mutant Tumors C Fedele, S Li, KW Teng, C Foster, D Peng, H Ran, P Mita, M Geer, ... bioRxiv, 2020.05. 30.125138, 2020 | 3 | 2020 |
| Regulation of T Cell Responses by SHP1 and SHP2 CJR Foster New York University, 2023 | | 2023 |
